April 26 (Reuters) - Edwards Lifesciences Corp on
Tuesday raised its full-year sales and profit outlook following
strong first-quarter results and said approval for expanded use
of its minimally invasive heart valve implant could come sooner
than previously expected.
Read more
No comments:
Post a Comment